search
Back to results

Efficacy of an Active Geriatric Evaluation for Geriatric Syndromes to Prevent Functional Decline in Family Medicine (AGE3)

Primary Purpose

Geriatric Syndrome, Functional Ability

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Active Geriatric Evaluation (AGE tool)
Usual care
Sponsored by
University of Lausanne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Geriatric Syndrome focused on measuring primary health care

Eligibility Criteria

75 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged 75 years or more
  • Consider the enrolling physician as his/her reference FP
  • Able to understand French
  • Living at home (not in institutions)
  • Visited his/her FP at least twice during the past year
  • Giving signed informed consent (or, in the absence of discerning capacity, giving assent in the presence of a surrogate signing the consent form)

Exclusion Criteria:

  • Having had a geriatric or specialized memory consultation in the past 3 months (including assessment during rehabilitation)
  • Planning to leave the study area or to change of FP in the next 2 years

Sites / Locations

  • Department of Ambulatory Care and Community Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Active Geriatric Evaluation (AGE tool)

Usual care

Arm Description

The Active Geriatric Evaluation is a comprehensive assessment and management tool consisting of a 20-minute clinical screening instrument (Brief Assessment Tool, BAT) to identify 8 geriatric syndromes, and complementary diagnostic evaluations and propositions of management & treatment for each syndrome.

No specific intervention will be provided to the patients, except what family practitioners (FPs) usually do. In this regard, it is possible that some FPs might use structured interventions similar to the AGE tool. This will be neither encouraged nor discouraged. FPs in the "usual care" arm will be asked to perform one BAT after 2 years of follow-up, at the final patient visit.

Outcomes

Primary Outcome Measures

Instrumental Activities of Daily Living (IADL)
Proportion of patients losing at least 1 instrumental IADL (8 items developed to assess functional status)
Basic Activities of Daily Living (ADL)
Proportion of patients losing at least 1 basic ADL (6 items developed to assess functional status)

Secondary Outcome Measures

Incidence of hospital admissions
Number of hospital admissions per patient per year
Incidence of institutionalization
Number of institutionalization per patient per year
Incidence of emergency visits
Number of emergency visits per patient per year
Incidence of outpatient visits
Number of outpatient visits to GP per patient per year
Health related quality of life (WHOQOL-OLD) score
questionnaire composed of 24 items. This broadly validated instrument is composed of six facets: 1) Sensory abilities, 2) Autonomy, 3) Past, present and future activities, 4) Social participation, 5) Death and dying and 6) Intimacy

Full Information

First Posted
November 24, 2015
Last Updated
February 18, 2021
Sponsor
University of Lausanne
search

1. Study Identification

Unique Protocol Identification Number
NCT02618291
Brief Title
Efficacy of an Active Geriatric Evaluation for Geriatric Syndromes to Prevent Functional Decline in Family Medicine
Acronym
AGE3
Official Title
Efficacy of a an Active Geriatric Evaluation (AGE Tool) for Geriatric Syndromes to Prevent Functional Decline in Elderly Patients in Family Medicine: a Pragmatic Cluster Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
June 2016 (Actual)
Primary Completion Date
January 31, 2020 (Actual)
Study Completion Date
January 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Lausanne

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to test the efficacy of a comprehensive assessment and management tool (AGE: Active Geriatric Evaluation) for geriatric syndromes to prevent functional decline in elderly patients followed in family medicine. Family practitioners will be randomised either to the intervention, consisting of a yearly screening for eight geriatric syndromes accompanied by a management plan in case of positive screening, or to usual care. Level of functioning and quality of life of patients in both arms will be assessed over two years.
Detailed Description
The ageing of the population is associated to a rapid increase of chronic conditions and more specifically geriatric syndromes for which the health care system is largely unprepared. Being in frontline of this huge arising burden, family practitioners (FP) will need adapted tools to identify and manage elderly patients with complex needs and prevent functional decline while improving quality of life. It is however well recognized that effective and efficient evidence-based interventions adapted to the primary care setting are lacking. The AGE program (Active Geriatric Evaluation) was launched in 2011 and aimed at developing a comprehensive assessment and management tool for FP's to better identify and manage geriatric syndromes. The AGE tool consists of a 20-minute clinical screening instrument (Brief Assessment Tool, BAT), which performances for identifying geriatric syndromes was already assessed in general practice along the AGE program, and a comprehensive approach that encompasses: complementary diagnostic evaluations and propositions of management & treatment for each syndrome. The efficacy and efficiency of the AGE tool for preventing functional decline was never assessed in real life settings of general practice. The aim of the study is to determine whether a comprehensive tool combining a brief assessment tool (BAT) for the early diagnosis of geriatric syndromes with a structured diagnostic and management strategy impacts on the functional decline and quality of life of elderly patients. Design: Two-arm open label cluster randomized trial in FP practices, randomization unit: FP Participants and setting: FP's and their patients aged ≥ 75 years in the French part of Switzerland. In total: 40 FP's (2x20) and 400 patients (2 x 200) Intervention: Active Geriatric Evaluation. Controls: Usual care provided by FP's. Duration of study: 3 years (2 years of follow-up). Expected outcomes:functional ability of patients in the intervention arm ,measured through the activities of daily living, will be conserved compared to patients in the usual care arm.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Geriatric Syndrome, Functional Ability
Keywords
primary health care

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
429 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active Geriatric Evaluation (AGE tool)
Arm Type
Experimental
Arm Description
The Active Geriatric Evaluation is a comprehensive assessment and management tool consisting of a 20-minute clinical screening instrument (Brief Assessment Tool, BAT) to identify 8 geriatric syndromes, and complementary diagnostic evaluations and propositions of management & treatment for each syndrome.
Arm Title
Usual care
Arm Type
Active Comparator
Arm Description
No specific intervention will be provided to the patients, except what family practitioners (FPs) usually do. In this regard, it is possible that some FPs might use structured interventions similar to the AGE tool. This will be neither encouraged nor discouraged. FPs in the "usual care" arm will be asked to perform one BAT after 2 years of follow-up, at the final patient visit.
Intervention Type
Other
Intervention Name(s)
Active Geriatric Evaluation (AGE tool)
Other Intervention Name(s)
Active geriatric evaluation
Intervention Description
Yearly administration of the brief assessment tool (BAT). Once the presence of one or more geriatric syndromes is suspected using the brief assessment tool, a management strategy is proposed. It is divided in two distinct steps: 1) perform additional tests to confirm or exclude the diagnosis and 2) to propose specific management attitudes. All proposed attitudes are based on literature review and geriatrician expertise. The FP remains free to follow the proposed attitudes.
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
No specific intervention will be provided to the patients, except what family practitioners (FPs) usually do. In this regard, it is possible that some FPs might use structured interventions similar to the AGE tool. This will be neither encouraged nor discouraged. FPs in the "usual care" arm will be asked to perform one BAT after 2 years of follow-up, at the final patient visit.
Primary Outcome Measure Information:
Title
Instrumental Activities of Daily Living (IADL)
Description
Proportion of patients losing at least 1 instrumental IADL (8 items developed to assess functional status)
Time Frame
2 years
Title
Basic Activities of Daily Living (ADL)
Description
Proportion of patients losing at least 1 basic ADL (6 items developed to assess functional status)
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Incidence of hospital admissions
Description
Number of hospital admissions per patient per year
Time Frame
During 2 years
Title
Incidence of institutionalization
Description
Number of institutionalization per patient per year
Time Frame
During 2 years
Title
Incidence of emergency visits
Description
Number of emergency visits per patient per year
Time Frame
During 2 years
Title
Incidence of outpatient visits
Description
Number of outpatient visits to GP per patient per year
Time Frame
During 2 years
Title
Health related quality of life (WHOQOL-OLD) score
Description
questionnaire composed of 24 items. This broadly validated instrument is composed of six facets: 1) Sensory abilities, 2) Autonomy, 3) Past, present and future activities, 4) Social participation, 5) Death and dying and 6) Intimacy
Time Frame
2 years
Other Pre-specified Outcome Measures:
Title
Adhesion to Active Geriatric Evaluation Tool
Description
Proportion of GPs completing the difference sections of the Active Geriatric Evaluation Tool
Time Frame
2 years
Title
Total cost
Description
Comparison, by arm, of total cost, corresponding to the sum of costs billed by FPs, drug prescriptions, hospital and institutional admission costs
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged 75 years or more Consider the enrolling physician as his/her reference FP Able to understand French Living at home (not in institutions) Visited his/her FP at least twice during the past year Giving signed informed consent (or, in the absence of discerning capacity, giving assent in the presence of a surrogate signing the consent form) Exclusion Criteria: Having had a geriatric or specialized memory consultation in the past 3 months (including assessment during rehabilitation) Planning to leave the study area or to change of FP in the next 2 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas Senn, MD PhD
Organizational Affiliation
Department of community medicine and ambulatory care, University of Lausanne
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Ambulatory Care and Community Medicine
City
Lausanne
State/Province
Vaud
ZIP/Postal Code
1011
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
34426445
Citation
Mueller Y, Schwarz J, Monod S, Locatelli I, Senn N. Use of standardized brief geriatric evaluation compared with routine care in general practice for preventing functional decline: a pragmatic cluster-randomized trial. CMAJ. 2021 Aug 23;193(33):E1289-E1299. doi: 10.1503/cmaj.202887.
Results Reference
derived
PubMed Identifier
31845213
Citation
Schnegg D, Senn N, Bugnon O, Schwarz J, Mueller Y. Drug Prescription in Older Swiss Men and Women Followed in Family Medicine. Drugs Real World Outcomes. 2020 Mar;7(1):87-95. doi: 10.1007/s40801-019-00175-6.
Results Reference
derived

Learn more about this trial

Efficacy of an Active Geriatric Evaluation for Geriatric Syndromes to Prevent Functional Decline in Family Medicine

We'll reach out to this number within 24 hrs